Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited
about
sameAs
Kawasaki Disease: A Clinician's UpdateThe diagnosis and management of Kawasaki diseaseHigh-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki DiseasePlatelet Endothelial Cell Adhesion Molecule-1 Gene Polymorphisms are Associated with Coronary Artery Lesions in the Chronic Stage of Kawasaki Disease.Is high-dose aspirin necessary in the acute phase of kawasaki disease?Management of acute and refractory Kawasaki disease.An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes.Comparative effectiveness of intravenous immunoglobulin from different manufacturing processes on Kawasaki disease.Vaccines and Kawasaki disease.Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity.Kawasaki disease: etiopathogenesis and novel treatment strategies.Preventing coronary artery lesions in Kawasaki disease.Anti-platelet agents in pediatric cardiac practice.Kawasaki disease in Greek children: a retrospective study.Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients.Treatment Options for Resistant Kawasaki Disease.Survey of aspirin use in Sturge-Weber syndrome.Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial.
P2860
Q26998791-E786D497-6374-416B-978A-9F988D19D9B2Q28211402-F26C4101-761E-4C47-AD10-4FBA46D62D62Q28396984-2BC3F204-D808-4AF1-BA9C-A0BA062242FAQ33729848-EC15B269-7F69-4551-9EB1-CFA447B41D3AQ36774715-B02CC492-E335-424C-9E9F-B50C2AC70F89Q38063969-4D100ED4-4A74-4415-B2D1-3246AE5399B4Q38104467-E0909ED3-797D-4048-AA02-BFCA6665B200Q38209742-2147D92B-4B67-4F40-902A-294D084719A1Q38658339-31E6521C-E4D5-4A32-9B75-440B5E1C8139Q38842992-33CDBCB3-C32B-4B76-9903-486E7FA8286FQ38945126-1D1EFBC7-02EB-489B-BC70-589C8CF1B3C2Q39399053-B47A9B9A-F77F-49FE-8F71-8D334D692336Q40036899-62B5AF22-A512-4878-BC06-E0FCEDC9532CQ40295189-B227A303-12EE-44B3-89B9-598EE56BB699Q42759549-8C694024-76F6-405E-AB80-914C2241E8D3Q47660588-0F96B551-FF7D-40C3-A281-336E07B2FC69Q51877815-95053F49-24E6-4C0A-B55B-DFEEC19706E8Q55446513-6CD249BD-7449-40A1-B018-4D4FB0BB247C
P2860
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited
@ast
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited
@en
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited
@nl
type
label
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited
@ast
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited
@en
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited
@nl
prefLabel
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited
@ast
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited
@en
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited
@nl
P2093
P3181
P356
P1433
P1476
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited
@en
P2093
Cheng-Liang Lee
Chu-Chuan Lin
Kai-Sheng Hsieh
Ken-Pen Weng
Shih-Ming Huang
Ta-Cheng Huang
P304
P3181
P356
10.1542/PEDS.2004-1037
P407
P577
2004-12-01T00:00:00Z